Dr. Maryann M. Shango, MD

Dr. Shango practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Shango's NPI, 1942593876, was assigned on May 25, 2011. Dr. Shango graduated from Wayne State University School of Medicine in 2011. Dr. Shango holds Oregon license MD198359.

Dr. Shango's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Shango's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Shango is also affiliated with Providence St. Vincent Medical Center. The medical group on file is Michigan Healthcare Professionals, P.C. Dmand AI also links Dr. Shango to 3 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shango practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Shango's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Shango's licenses on file in 3 states: Oregon, Michigan and Washington.

CMS data shows 58,021 Medicare services from Dr. Shango across 47 procedure codes in 2024, for 403 Medicare patients. Medicare paid $494,731 for them. Every service was in an office.

CMS counts 403 Medicare patients who saw Dr. Shango in 2024. The largest group is 65 to 74, with 193 patients. 66% of them have high blood pressure, and 65% have cancer. 6% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shango's median patient age at 68, with 66% women.

In 2024, Dr. Shango wrote 1,195 Medicare Part D claims for 232 patients. 84% of them were for generic drugs. CMS names the drug for 947 of them, across 24 drugs with 11 or more claims each, at $1,374,210 in total drug cost. In 2023, CMS named 1,055 claims across 24 drugs.

Dr. Shango accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Shango, published from 2010 to 2020. 2012 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents, beta-Lactam Resistance and Carbapenems. Dr. Shango has published most often in Infect Control Hosp Epidemiol. Dr. Shango's most frequent co-authors are Teena Chopra, MD, Sorabh Dhar, MD and Kayoko Hayakawa, MD.

CMS Open Payments shows 5 general payments to Dr. Shango from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 78% of the total. GE Healthcare paid the most, $133.

Dr. Shango graduated from Wayne State University School of Medicine in 2011.